Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-017030

Director acquired 6,407 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2023-12-01 Other acquisition 10b5-1 +379 $1.69 $641 230,249 D
Krogulski Kenneth Director 2023-12-04 Other acquisition 10b5-1 +322 $1.72 $554 230,571 D
Krogulski Kenneth Director 2023-12-05 Other acquisition 10b5-1 +379 $1.69 $641 230,950 D
Krogulski Kenneth Director 2023-12-06 Other acquisition 10b5-1 +379 $1.70 $644 231,329 D
Krogulski Kenneth Director 2023-12-07 Other acquisition 10b5-1 +174 $1.65 $287 231,503 D
Krogulski Kenneth Director 2023-12-08 Other acquisition 10b5-1 +379 $1.83 $694 231,882 D
Krogulski Kenneth Director 2023-12-11 Other acquisition 10b5-1 +434 $1.85 $803 232,316 D
Krogulski Kenneth Director 2023-12-12 Other acquisition 10b5-1 +456 $1.77 $807 232,772 D
Krogulski Kenneth Director 2023-12-13 Other acquisition 10b5-1 +434 $1.80 $781 233,206 D
Krogulski Kenneth Director 2023-12-14 Other acquisition 10b5-1 +434 $1.86 $807 233,640 D
Krogulski Kenneth Director 2023-12-15 Other acquisition 10b5-1 +434 $1.89 $820 234,074 D
Krogulski Kenneth Director 2023-12-18 Other acquisition 10b5-1 +407 $1.80 $733 234,481 D
Krogulski Kenneth Director 2023-12-19 Other acquisition 10b5-1 +407 $1.73 $704 234,888 D
Krogulski Kenneth Director 2023-12-20 Other acquisition 10b5-1 +628 $1.76 $1,105 235,516 D
Krogulski Kenneth Director 2023-12-21 Other acquisition 10b5-1 +761 $1.70 $1,294 236,277 D
Loading xslF345X05/marketforms-63935.xml…